首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1820476

全球糞便隱血檢測市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Fecal Occult Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年09月01日 | 出版商:

Value Market Research | 英文 109 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球糞便隱匿性檢測市場預計將大幅成長，到 2033 年將達到 26.2 億美元，高於 2024 年的 16.2 億美元。預計 2025 年至 2033 年期間該市場的年複合成長率(CAGR) 為 5.46%。

隨著大腸癌篩檢計畫的增加以及人們對早期檢測益處的認知不斷提高，糞便隱血檢測 (FOT) 市場正在不斷擴大。 FOT 是一種非侵入性診斷工具，可以檢測糞便樣本中的隱血，在旨在降低癌症死亡率的全民篩檢計畫中發揮至關重要的作用。技術進步正在提高檢測的靈敏度、特異性和易用性，免疫化學和基於 DNA 的檢測方法的發展提高了診斷的準確性。與數位健康平台和電子病歷的整合正在簡化患者管理和隨訪流程。

家用檢測試劑盒的普及化正在提升檢測的可近性和依從性，尤其是在醫療資源匱乏和偏遠地區。法規核准和報銷政策的訂定正在促進其在醫療保健體系中的廣泛應用。此外，將FOT與其他生物標記結合的多重檢測技術正在興起，提供全面的篩檢解決方案。個人化醫療和風險分層的日益普及，推動了對支持客製化篩檢間隔和干涉措施的先進診斷工具的需求。

診斷公司、醫療保健提供者和公共衛生組織之間的合作正在加速創新和宣傳活動。隨著全球大腸直腸癌發生率的上升，糞便潛血檢測市場可望持續成長，為早期診斷、改善患者預後和降低醫療成本做出重大貢獻。

我們的報告經過精心設計，旨在為客戶提供關於各個行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵部分，以確保客戶全面了解市場格局：

市場概況：對市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本部分探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準，將市場細分為不同的細分市場。此分析重點在於突出每個細分市場的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本部分深入分析了領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，對特定時期的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示，以說明未來的市場發展軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前及新興市場趨勢、技術創新和潛在投資領域。本部分提供對未來市場發展和成長前景的洞察。

涵蓋的細分市場列表

糞便隱匿檢測市場報告的此部分提供了國家和地區層面的詳細資料，從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

按測試類型

癒創木脂 FOB 糞便測試
免疫FOB凝集試驗
側流免疫FOB檢測
免疫FOB ELISA檢測

按最終用途

醫院
診斷中心
其他
報告中介紹的公司列表
Humasis.Com、CTK Biotech Inc.、Biopanda Reagents Ltd、Biohit Oyj、Certest Biotec、Cenogenics Corporation、Alfa Scientific Designs Inc.、Siemens Healthcare GmbH、Jant Pharmacal Corporation、Quidel Corporation、Wondfo

如果您有任何客製化需求，請聯絡我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第 8 章：糞便隱血檢測公司的競爭格局

糞便隱血檢測市場競爭
夥伴關係/合作/協議
併購
新產品發布
其他發展

第9章：公司簡介

頂級公司市佔率分析
市場集中度
HUMASIS.COM

公司概況
公司收入
產品
最新動態

CTK Biotech Inc.

公司概況
公司收入
產品
最新動態

Biopanda Reagents Ltd

公司概況
公司收入
產品
最新動態

Biohit Oyj

公司概況
公司收入
產品
最新動態

CERTEST BIOTEC

公司概況
公司收入
產品
最新動態

Cenogenics Corporation

公司概況
公司收入
產品
最新動態

Alfa Scientific Designs Inc.

公司概況
公司收入
產品
最新動態

Siemens Healthcare GmbH

公司概況
公司收入
產品
最新動態

Jant Pharmacal Corporation

公司概況
公司收入
產品
最新動態

Quidel Corporation

公司概況
公司收入
產品
最新動態

Wondfo

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，或者在私人公司的情況下可能不涵蓋

簡介目錄圖表

Product Code: VMR112117554

Global Fecal Occult Testing Market is poised to witness substantial growth, reaching a value of USD 2.62 Billion by the year 2033, up from USD 1.62 Billion attained in 2024. The market is anticipated to display a Compound Annual Growth Rate (CAGR) of 5.46% between 2025 and 2033.

The fecal occult testing (FOT) market is expanding in response to increasing colorectal cancer screening initiatives and growing awareness of early detection benefits. FOT, a non-invasive diagnostic tool that detects hidden blood in stool samples, plays a crucial role in population-wide screening programs aimed at reducing cancer mortality. Technological advancements are enhancing test sensitivity, specificity, and ease of use, with developments in immunochemical and DNA-based assays providing improved diagnostic accuracy. Integration with digital health platforms and electronic medical records is streamlining patient management and follow-up processes.

The shift towards at-home testing kits is increasing accessibility and compliance, particularly in underserved and remote populations. Regulatory approvals and reimbursement policies are facilitating broader adoption across healthcare systems. Additionally, multiplex testing capabilities that combine FOT with other biomarkers are emerging, offering comprehensive screening solutions. The growing emphasis on personalized medicine and risk stratification is driving demand for advanced diagnostic tools that support tailored screening intervals and interventions.

Collaborations among diagnostic companies, healthcare providers, and public health organizations are accelerating innovation and awareness campaigns. As colorectal cancer incidence rises globally, the fecal occult testing market is positioned for sustained growth, contributing significantly to early diagnosis, improved patient outcomes, and healthcare cost reduction.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Fecal Occult Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

Guaiac FOB stool test
Immuno-FOB agglutination test
Lateral flow immuno-FOB test
Immuno-FOB ELISA test

By End-use

Hospitals
Diagnostic centers
Others
List of Companies Profiled in the report
Humasis.Com, CTK Biotech Inc., Biopanda Reagents Ltd, Biohit Oyj, Certest Biotec, Cenogenics Corporation, Alfa Scientific Designs Inc., Siemens Healthcare GmbH, Jant Pharmacal Corporation, Quidel Corporation, Wondfo

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. FECAL OCCULT TESTING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Test Type
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL FECAL OCCULT TESTING MARKET ANALYSIS BY TEST TYPE

5.1. Overview By Test Type
5.2. Historical and Forecast Data Analysis By Test Type
5.3. Guaiac FOB stool test Historic and Forecast Sales By Regions
5.4. Immuno-FOB agglutination test Historic and Forecast Sales By Regions
5.5. Lateral flow immuno-FOB test Historic and Forecast Sales By Regions
5.6. Immuno-FOB ELISA test Historic and Forecast Sales By Regions

6. GLOBAL FECAL OCCULT TESTING MARKET ANALYSIS BY END-USE

6.1. Overview By End-use
6.2. Historical and Forecast Data Analysis By End-use
6.3. Hospitals Historic and Forecast Sales By Regions
6.4. Diagnostic centers Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL FECAL OCCULT TESTING MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE FECAL OCCULT TESTING COMPANIES

8.1. Fecal Occult Testing Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF FECAL OCCULT TESTING INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. HUMASIS.COM
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. CTK Biotech Inc.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Biopanda Reagents Ltd
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Biohit Oyj
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. CERTEST BIOTEC
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Cenogenics Corporation
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Alfa Scientific Designs Inc.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Siemens Healthcare GmbH
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Jant Pharmacal Corporation
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Quidel Corporation
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Wondfo
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments